AI ASSISTANT
Ask DrugCentral
Explore drug information in your own words.
Type a question in the search bar above to get started. Each question is answered independently.
AI can make mistakes. Verify answers against the original sources before relying on them.
fenspiride 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 1163 | 5053-06-5 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
|
Drug dosage:
None
ADMET properties:
| Property | Value | Reference |
|---|---|---|
| BA (Bioavailability) | 90 % | Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H |
| Vd (Volume of distribution) | 3 L/kg | Lombardo F, Berellini G, Obach RS |
| CL (Clearance) | 2.60 mL/min/kg | Lombardo F, Berellini G, Obach RS |
| t_half (Half-life) | 14 hours | Lombardo F, Berellini G, Obach RS |
Predicted pharmacokinetic/toxicological properties (PK-AZ):
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| azlogd74 | LogD at pH 7.4 | 0.858 | High | 1 | |
| caco2-efflux | Caco-2 efflux ratio (BA/AB) | 2.506 | High | 1 | |
| caco2-intrinsic-papp | Caco-2 intrinsic apparent permeability | 10.789 | 10^-6 cm/s | High | 1 |
| dh-clint | Dog hepatocyte intrinsic clearance | 2.223 | uL/min/10^6 cells | High | 1 |
| dppb | Dog plasma protein binding (% unbound) | 68.930 | % | High | 1 |
| fcs-ppb | Fetal calf serum protein binding (% unbound) | 73.360 | % | High | 1 |
| herg | hERG pIC50 | 4.960 | pIC50 | High | 1 |
| hh-clint | Human hepatocyte intrinsic clearance | 1.109 | uL/min/10^6 cells | High | 1 |
| hlm-clint | Human liver microsomal intrinsic clearance | 3.475 | uL/min/mg protein | High | 1 |
| hppb | Human plasma protein binding (% unbound) | 80.330 | % | High | 1 |
| kinase-safety-class | ACVR2B,AXL,BRAF,CAMK2B,CAMK2D,CDK5,CDK9,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,ITK,MAP3K21,MAPK7,MET,NTRK2,PDK1,PDK2,PDK4,PIK3CB,PRKDC,SIK2,SIK3,TEK | 25 | |||
| kinase-selectivity-class | AXL,BRAF,CAMK2D,CDK9,DDR1,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,MAPK7,PRKCD,SIK2,SIK3,STK33,TEK | 16 | |||
| mdck-mdr1-efflux | MDCK-MDR1 efflux ratio | 2.877 | High | 1 | |
| mh-clint | Mouse hepatocyte intrinsic clearance | 4.436 | High | 1 | |
| mppb | Mouse plasma protein binding (% unbound) | 69.660 | High | 1 | |
| nih-mdck-mdr1-efflux | NIH MDCK-MDR1 efflux ratio | 8.395 | High | 1 | |
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 | |||
| pppb | Pig plasma protein binding (% unbound) | 79.330 | % | High | 1 |
| rh-clint | Rat hepatocyte intrinsic clearance | 3.990 | uL/min/10^6 cells | High | 1 |
| rh-fuinc | Rat hepatocyte fraction unbound in incubation | 91.020 | % | High | 1 |
| rppb | Rat plasma protein binding (% unbound) | 72.820 | % | High | 1 |
| solubility-dd | Solubility at pH 7.4 in DMSO | 1004.616 | uM | High | 1 |
Approvals:
None
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | R03BX01 | RESPIRATORY SYSTEM DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS Other drugs for obstructive airway diseases, inhalants |
| ATC | R03DX03 | RESPIRATORY SYSTEM DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES Other systemic drugs for obstructive airway diseases |
| MeSH PA | D001993 | Bronchodilator Agents |
| MeSH PA | D018373 | Peripheral Nervous System Agents |
| MeSH PA | D018927 | Anti-Asthmatic Agents |
| MeSH PA | D019141 | Respiratory System Agents |
Related Drugs by ATC class:
R03BX Other drugs for obstructive airway diseases, inhalants 1 drug
R03DX Other systemic drugs for obstructive airway diseases 10 drugs
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 9.16 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| D04163 | KEGG_DRUG |
| C0015843 | UMLSCUI |
| CHEBI:94558 | CHEBI |
| CHEMBL576127 | ChEMBL_ID |
| DB08979 | DRUGBANK_ID |
| CHEMBL1256849 | ChEMBL_ID |
| C084775 | MESH_SUPPLEMENTAL_RECORD_UI |
| 3344 | PUBCHEM_CID |
| 2577 | INN_ID |
| 5053-08-7 | SECONDARY_CAS_RN |
| S983QC7HKM | UNII |
| 236281 | RXNORM |
| 005567 | NDDF |
| 005568 | NDDF |
| 712690002 | SNOMEDCT_US |
| 712691003 | SNOMEDCT_US |
| S983QC7HKM | INXIGHT DRUGS |
Pharmaceutical products:
None